Alon Natanson, has resigned as Chief Executive Officer of Brainstorm Cell Therapeutics after a short term in the position. He has been replaced by Chaim Lebovits, the President of the
Company. Lebovits controls ACC HOLDINGS INTERNATIONAL, and its subsidiaries ACC Resources, specializing in the mining, oil, and energy industries, and ACC BioTech, which is focused on biotechnology. Lebovits has also held senior positions for the worldwide Chabad Lubavitch organization.